This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Blueprint Medicines Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Brenton Mar: Innovator in Pharmaceutical Development
Introduction
Brenton Mar is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on developing innovative treatments for various medical conditions, particularly those associated with oncogenic alterations.
Latest Patents
Brenton Mar holds a patent for a novel compound titled "Dosing regimens of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for treatment of indolent systemic mastocytosis." This patent includes crystalline forms of the compound, pharmaceutically acceptable salts, and solvates. It also discloses pharmaceutical compositions and methods for treating disorders associated with oncogenic KIT and PDGFRA alterations.
Career Highlights
Brenton Mar is currently associated with Blueprint Medicines Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating effective therapies that address critical health issues.
Collaborations
Brenton collaborates with esteemed colleagues, including Anthony L Boral and Hui-Min Lin, to enhance the impact of his research and drive innovation in the pharmaceutical industry.
Conclusion
Brenton Mar's contributions to pharmaceutical innovation exemplify the vital role of inventors in advancing medical science. His patent and ongoing work at Blueprint Medicines Corporation highlight his commitment to improving patient outcomes through innovative treatments.